Research Article
Volume 19 Issue 10 - 2020
Low-Level Laser Improves Quality of Life for Patients with Burning Mouth Syndrome. A Systematic Review and Meta-Analysis
Jon Salazar Cantero1, Mario Utrilla Trinidad2*, Igone Burguera Martinez3, Borja Salazar Cantero3 and Evaristo Rambla Alonso1
1Doctor in Dentistry, University of Basque Country, Spain
2Doctor in Dentistry, MBA in Healthcare Management, Director of the Master in Management and Direction of Dental Clinics, Spain
3University of Basque Country, Spain
*Corresponding Author: Mario Utrilla Trinidad, Doctor in Dentistry, MBA in Healthcare Management, Director of the Master in Management and Direction of Dental Clinics, Spain.
Received: June 29, 2020; Published: September 24, 2020




Abstract

Purpose: The aim of this systematic review is to evaluate if laser therapy produces an improvement in the values of quality of life related with oral health in patients affected by burning mouth syndrome.

Methods: An electronic searches was conducted in April 2020. Five Databases were searched inspected: Medline via Pubmed, Embase via Ovid, Cochrane Central, Scopus and Web of Science. Only Randomized clinical trials with placebo group were included.

Results: 324 article were identified and but only 6 were included. Five studies showed statistically significant differences between laser and placebo groups after treatment. The mean difference in studies between laser and placebo groups at the last session was from 3.5 to 15 points in favor of laser. The meta-analysis was carried out with five studies with data from baseline, last sessions and 4 weeks after. The results of the meta-analysis indicate statistically significant OHIP-14 scores for the laser versus placebo group both at the end of treatment and at 4 weeks, 5.05 (IC95% 7.02 - 3.08) and 2.98 (IC95% 4.31 - 1.64) respective respectively.

Conclusion: Low-Level Laser therapy produces an statistically significant improvement in OHrQoL scores. This non-invasive technique could be an option to treat the symptoms of BMS with fewer adverse effects than conventional drug treatments. More randomized clinical trials with longer follow-ups and larger samples and bigger sample sizes are needed.

Keywords: Low-Level Laser Therapy; LLLT; Photobiomodulation; Burning Mouth Syndrome; BMS; Oral Health Related with Quality of Life; OHrQoL; OHIP-14

References

  1. Sun Andy., et al. “Burning mouth syndrome: a review and update”. Journal of oral pathology and medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology9 (2013): 649-655.
  2. López-Jornet P., et al. “Burning mouth syndrome: an update”. Medicina Oral Patologia Oral y Cirugia Bucal 4 (2010): e562-e568.
  3. Jimson S., et al. “Burning mouth syn- drome”. Journal of Pharmacy and Bioallied Sciences 7 (2015): 194-196.
  4. Aggarwal Ashish and Sunil R Panat. “Burning mouth syndrome: A diagnostic and therapeutic dilemma”. Journal of Clinical and Experimental Dentistry3 (2012): e180-e155.
  5. Romeo Umberto., et al. “The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study”. Annali Di Stomatologia1 (2010): 14-18.
  6. Lauria G., et al. “Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome”. Pain 3 (2005): 332-337.
  7. Tarkkila L., et al. “Oral symptoms at menopause--the role of hormone replacement therapy”. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, And Endodontics3 (2001): 276-280.
  8. Takenoshita Miho., et al. “Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities”. Neuropsychiatric Disease and Treatment 6 (2010): 699-705.
  9. Heckmann Siegfried M., et al. “A double-blind study on clonazepam in patients with burning mouth syndrome”. The Laryngoscope 4 (2012): 813-816.
  10. Guarneri Fabrizio., et al. “Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use”. Dermatologic Therapy 2 (2008): S21-S24.
  11. Kisely Steve., et al. “A systematic review of randomized trials for the treatment of burning mouth syndrome”. Journal of Psychosomatic Research 86 (2016): 39-46.
  12. Dos Santos., et al. “Effect of low-level laser therapy in the treatment of burning mouth syndrome: a case series”. Photomedicine and Laser Surgery12 (2011): 793-796.
  13. Pezelj-Ribarić Sonja., et al. “Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy”. Lasers in Medical Science1 (2013): 297-301.
  14. Arduino Paolo G., et al. “A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome”. Lasers in Medical Science4 (2016): 811-816.
  15. Zarei M., et al. “Low level laser therapy and hair regrowth: an evidence-based review”. Lasers in Medical Science 2 (2016): 363-371.
  16. Glazov G., et al. “Low-level laser therapy for chronic non-specific low back pain: a meta-analysis of randomised controlled trials”. Acupuncture in Medicine5 (2016): 328-341.
  17. Mizutani K., et al. “A clinical study on serum prostaglandin E2 with low-level laser therapy”. Photomedicine, and Laser Surgery 6 (2004): 537-539.
  18. Silva Geisa Badauy Lauria., et al. “Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study”. Lasers in Medical Science1 (2015): 117-126.
  19. Kressin NR. “The Oral Health Related Quality of Life Measure (OHQOL)”. In: Slade GD, editor. Measuring oral health and quality of life. Chapel Hill: University of North Carolina, Dental Ecology (1997): 114-119.
  20. Locker David and Finbarr Allen. “What do measures of 'oral health-related quality of life' measure?”. Community Dentistry and Oral Epidemiology 6 (2007): 401-411.
  21. López-Jornet P., et al. “Quality of life in patients with burning mouth syndrome”. Journal of Oral Pathology and Medicine 7 (2008): 389‐394.
  22. Souza Fabrício TA., et al. “The impact of burning mouth syndrome on health-related quality of life”. Health and Quality of Life Outcomes 9 (2011): 57.
  23. Ni Riordain R., et al. “Burning mouth syndrome and oral health-related quality of life: is there a change over time?” Oral Diseases 7 (2010): 643‐647.
  24. Liberati Alessandro., et al. “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration”. British Medical Journal 339 (2009): b2700.
  25. Arbabi-Kalati Fateme., et al. “Evaluation of the efficacy of low-level laser in improving the symptoms of burning mouth syndrome”. Journal of Clinical and Experimental Dentistry4 (2015): e524-e527.
  26. Sikora Miroslav., et al. “The Efficacy of Low-Level Laser Therapy in Burning Mouth Syndrome - A Pilot Study”. Acta Clinica Croatica 2 (2018): 312-315.
  27. Valenzuela S and P Lopez-Jornet. “Effects of low-level laser therapy on burning mouth syndrome”. Journal of Oral Rehabilitation2 (2017): 125-132.
  28. Spanemberg Juliana Cassol., et al. “Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: a randomized, controlled trial”. Journal of Biomedical Optics9 (2015): 098001.
  29. Bardellini E., et al. “Efficacy of the photobiomodulation therapy in the treatment of the burning mouth syndrome”. Medicina Oral, Patologia Oral Y Cirugia Bucal6 (2019): e787-e791.
  30. Oliveira PS., et al. “Impact of root canal preparation performed by ProTaper Next or Reciproc on the quality of life of patients: a randomized clinical trial”. International Endodontic Journal2 (2019): 139-148.
  31. Navarro Morante Anabel., et al. “Natural products for the management of xerostomia: a randomized, double-blinded, placebo-controlled clinical trial”. Journal of Oral Pathology and Medicine 2 (2017): 154-160.
  32. John MT., et al. “Confirmatory factor analysis of the Oral Health Impact Profile”. Journal of Oral Rehabilitation9 (2014): 644-652.
  33. Myint Oo KZ., et al. “Minimal clinically important differences of oral health-related quality of life after removable partial denture treatments”. Journal of Dentistry 92 (2020): 103246.
  34. Tsakos Georgios., et al. “Interpreting oral health-related quality of life data”. Community Dentistry and Oral Epidemiology 3 (2012): 193-200.
Citation: Jon Salazar Cantero., et al. “Low-Level Laser Improves Quality of Life for Patients with Burning Mouth Syndrome. A Systematic Review and Meta-Analysis”. EC Dental Science 19.10 (2020): 107-118.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 04, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk